Key facts
- It has raised $27.2M; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include TriplePoint Capital, Octopus Ventures, London & Partners., Salica Investments, Mercia Ventures — 13 tracked in total.
- Semble has filed 2 Form Ds with the SEC, most recently Jul 2012 ($451K sold to 8 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Semble
- ·The full record, as it builds
Funding rounds
No funding rounds for Semble are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Semble
Developer of a cloud-based clinical system designed to cover all the medical and administration needs of the medical practice. The company's system aggregates, structures, and learns from data to benefit health professionals, patients, and clinical research, enabling practitioners to improve health outcomes for patients.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2015
- Employees
- 101
- Website
- semble.io/
- Ownership
- Privately Held (backing)
Semble doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Semble shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Semble in its N-PORT filings yet. We sweep new filings monthly.